Amy Comander

693 total citations
30 papers, 417 citations indexed

About

Amy Comander is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Amy Comander has authored 30 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Amy Comander's work include Cancer survivorship and care (9 papers), Advanced Breast Cancer Therapies (6 papers) and Breast Cancer Treatment Studies (6 papers). Amy Comander is often cited by papers focused on Cancer survivorship and care (9 papers), Advanced Breast Cancer Therapies (6 papers) and Breast Cancer Treatment Studies (6 papers). Amy Comander collaborates with scholars based in United States, Australia and New Zealand. Amy Comander's co-authors include Nadine Tung, Judy E. Garber, Stuart J. Schnitt, Larissa J. Lee, Brian M. Alexander, Aditya Bardia, Antonio C. Wolff, Mark R. Somerfield, Rachel A. Freedman and Melinda L. Telli and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Amy Comander

27 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy Comander United States	10	211	177	102	102	102	30	417
Yolanda Jerez Spain	12	297 1.4×	105 0.6×	83 0.8×	53 0.5×	123 1.2×	30	433
Christina Yeon United States	8	258 1.2×	70 0.4×	97 1.0×	85 0.8×	76 0.7×	26	367
Yiola Marcou Cyprus	11	197 0.9×	109 0.6×	75 0.7×	137 1.3×	243 2.4×	23	536
Karleen Habin United States	12	311 1.5×	156 0.9×	122 1.2×	132 1.3×	167 1.6×	27	520
Т. Yu. Semiglazova Russia	7	237 1.1×	71 0.4×	79 0.8×	34 0.3×	57 0.6×	140	367
Byung Kyun Ko South Korea	15	141 0.7×	127 0.7×	70 0.7×	47 0.5×	117 1.1×	37	429
Furkan Sarici Türkiye	10	263 1.2×	150 0.8×	78 0.8×	59 0.6×	93 0.9×	28	391
Sebastian Lundgren Sweden	10	389 1.8×	94 0.5×	104 1.0×	82 0.8×	71 0.7×	21	541
Ulrich Stein France	10	228 1.1×	109 0.6×	132 1.3×	40 0.4×	107 1.0×	28	502
Suzanne P. MacFarland United States	13	126 0.6×	74 0.4×	58 0.6×	89 0.9×	187 1.8×	45	527

Countries citing papers authored by Amy Comander

Since Specialization

Citations

This map shows the geographic impact of Amy Comander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Comander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Comander more than expected).

Fields of papers citing papers by Amy Comander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Comander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Comander. The network helps show where Amy Comander may publish in the future.

Co-authorship network of co-authors of Amy Comander

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Comander. A scholar is included among the top collaborators of Amy Comander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Comander. Amy Comander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hayes, Sandra C., et al.. (2025). Implementing Lifestyle Medicine in Cancer Survivorship: A Narrative Review of Global Models. American Journal of Lifestyle Medicine. 3004307749–3004307749. 1 indexed citations

Freedman, Rachel A., Jennifer L. Caswell‐Jin, Michael J. Hassett, et al.. (2024). Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer—Cyclin-Dependent Kinase 4 and 6 Inhibitors: ASCO Guideline Rapid Recommendation Update. Journal of Clinical Oncology. 42(18). 2233–2235. 18 indexed citations

Millstein, Rachel, et al.. (2024). Implementing a Multidisciplinary Lifestyle Medicine Clinic for Cancer Survivorship. PubMed. 38(3811). 421–425. 2 indexed citations

Medford, Arielle J., Douglas S. Micalizzi, Yael Bar, et al.. (2024). Abstract PO3-13-09: Personalized ctDNA testing for detection of molecular residual disease in patients with localized HR+ breast cancer: temporal dynamics and impact on clinical outcomes. Cancer Research. 84(9_Supplement). PO3–13. 1 indexed citations

Finkelstein‐Fox, Lucy, Daniel L. Hall, Areej El‐Jawahri, et al.. (2023). Do cancer curvivors and metavivors have distinct needs for stress management intervention? Retrospective analysis of a mind–body survivorship program. Supportive Care in Cancer. 31(10). 616–616. 2 indexed citations

Hall, Kimberly A. Arditte, Elyse R. Park, Mark Gorman, et al.. (2023). Treatment-related changes in insomnia, anticipatory pleasure, and depression symptoms: A proof-of-concept study with cancer survivors. Sleep Medicine. 103. 29–32. 3 indexed citations

Saraf, Anurag, G Sharp, Eric Roeland, et al.. (2023). Association of Sarcopenia With Toxicity-Related Discontinuation of Adjuvant Endocrine Therapy in Women With Early-Stage Hormone Receptor–Positive Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 118(1). 94–103. 4 indexed citations

Finkelstein‐Fox, Lucy, Daniel L. Hall, Giselle K. Perez, et al.. (2022). Testing psychosocial mediators of a mind–body resiliency intervention for cancer survivors. Supportive Care in Cancer. 30(7). 5911–5919. 3 indexed citations

O’Donnell, Elizabeth, Amy Comander, Steven J. Isakoff, et al.. (2022). Pilot study to assess prolonged overnight fasting in breast cancer survivors (longfast). Breast Cancer Research and Treatment. 193(3). 579–587. 8 indexed citations

10.

Spring, Laura M., Sara M. Tolaney, Neelam V. Desai, et al.. (2022). Phase 2 study of response-guided neoadjuvant sacituzumab govitecan (IMMU-132) in patients with localized triple-negative breast cancer: Results from the NeoSTAR trial.. Journal of Clinical Oncology. 40(16_suppl). 512–512. 27 indexed citations

11.

Hall, Daniel L., Kimberly A. Arditte Hall, Mark Gorman, et al.. (2021). The Survivorship Sleep Program (SSP): A synchronous, virtual cognitive behavioral therapy for insomnia pilot program among cancer survivors. Cancer. 128(7). 1532–1544. 12 indexed citations

12.

May, Christine N., Annabell Suh Ho, Meaghan McCallum, et al.. (2021). Comparing Outcomes of a Digital Commercial Weight Loss Program in Adult Cancer Survivors and Matched Controls with Overweight or Obesity: Retrospective Analysis. Nutrients. 13(9). 2908–2908. 4 indexed citations

13.

Jacobs, Jamie M., Michael H. Antoni, Elyse R. Park, et al.. (2020). Development and Refinement of a Telehealth Intervention for Symptom Management, Distress, and Adherence to Adjuvant Endocrine Therapy after Breast Cancer. Journal of Clinical Psychology in Medical Settings. 28(3). 603–618. 12 indexed citations

14.

Denduluri, Neelima, Mark R. Somerfield, Mariana Chávez‐MacGregor, et al.. (2020). Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update. Journal of Clinical Oncology. 39(6). 685–693. 76 indexed citations

15.

Spring, Laura M., Andrzej Niemierko, Stephanie Haddad, et al.. (2018). Effectiveness and tolerability of neoadjuvant pertuzumab-containing regimens for HER2-positive localized breast cancer. Breast Cancer Research and Treatment. 172(3). 733–740. 9 indexed citations

16.

Spring, Laura M., Andrzej Niemierko, Amy Comander, et al.. (2016). Tolerability and effectiveness of pertuzumab-containing neoadjuvant (NA) regimens vs. AC-TH for HER2-positive (+) localized breast cancer (BC).. Journal of Clinical Oncology. 34(15_suppl). 586–586.

17.

Fathi, Amir T., Hossein Sadrzadeh, Amy Comander, et al.. (2014). Isocitrate Dehydrogenase 1 (IDH1) Mutation in Breast Adenocarcinoma Is Associated With Elevated Levels of Serum and Urine 2-Hydroxyglutarate. The Oncologist. 19(6). 602–607. 59 indexed citations

18.

Lee, Larissa J., Brian M. Alexander, Stuart J. Schnitt, et al.. (2011). Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers. Cancer. 117(14). 3093–3100. 59 indexed citations

19.

Tung, Nadine, Yihong Wang, Laura C. Collins, et al.. (2010). Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features. Breast Cancer Research. 12(1). R12–R12. 69 indexed citations

20.

Comander, Amy & S A Cannistra. (2007). A feasibility study of low-dose, prolonged oral topotecan in patients with advanced ovarian, fallopian tube, or primary peritoneal serous cancer who have attained a complete clinical response following platinum-based chemotherapy. International Journal of Gynecological Cancer. 18(1). 51–58. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact